{"id":"conventional-glucocortidois","safety":{"commonSideEffects":[{"rate":null,"effect":"Hyperglycemia"},{"rate":null,"effect":"Hypertension"},{"rate":null,"effect":"Osteoporosis"},{"rate":null,"effect":"Infections (opportunistic)"},{"rate":null,"effect":"Cushingoid features"},{"rate":null,"effect":"Mood disturbances"},{"rate":null,"effect":"Gastrointestinal upset"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Glucocorticoids enter cells and bind to intracellular glucocorticoid receptors, which translocate to the nucleus and regulate transcription of pro-inflammatory and anti-inflammatory genes. This leads to decreased production of cytokines, chemokines, and adhesion molecules, reducing immune cell activation and migration. The result is broad immunosuppression and anti-inflammatory effects across multiple tissues.","oneSentence":"Conventional glucocorticoids suppress immune and inflammatory responses by binding to glucocorticoid receptors and modulating gene expression.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:07:39.181Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Inflammatory and autoimmune disorders (e.g., rheumatoid arthritis, lupus, vasculitis)"},{"name":"Allergic and asthmatic conditions"},{"name":"Adrenal insufficiency"},{"name":"Certain hematologic malignancies and lymphomas"}]},"trialDetails":[{"nctId":"NCT06260462","phase":"PHASE3","title":"Effects of Steroid Replacement Therapy on Metabolic, Cardiovascular and Bone Outcomes in Adrenal Insufficiency","status":"COMPLETED","sponsor":"University of Palermo","startDate":"2012-01-01","conditions":"Adrenal Insufficiency","enrollment":88}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["hydrocortisone","cortisone acetate"],"phase":"phase_3","status":"active","brandName":"Conventional glucocortidois","genericName":"Conventional glucocortidois","companyName":"University of Palermo","companyId":"university-of-palermo","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Conventional glucocorticoids suppress immune and inflammatory responses by binding to glucocorticoid receptors and modulating gene expression. Used for Inflammatory and autoimmune disorders (e.g., rheumatoid arthritis, lupus, vasculitis), Allergic and asthmatic conditions, Adrenal insufficiency.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}